Vidiyal vs NephX
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
Vidiyal
Read full descriptionHide full description
Tamil Nadu is one of the first States to initiate Cadaver Transplant in 1995 after the Transplantation of Human Organs Act was passed in the year 1994. Cadaver Transplant Program was started by the then Honβble Chief Minister Dr.Kalaignar.M.Karunanidhi in the year of 2008. Cadaver Transplant Programme was made a Government Society in May 2015 and named as Transplant Authority of Tamil Nadu under the Chairmanship of the Honourable Chief Minister of Tamil Nadu.
NephX
Read full descriptionHide full description
NephX is a secure messaging platform built exclusively for the nephrology community in India. WHY NEPHX EXISTS Every brilliant case discussion, every academic insight that happens in WhatsApp threads β most of it disappears. NephX exists to preserve the collective wisdom of Indian nephrology, structured and searchable for the next consultant, the next fellow, the next decade. WHAT'S INSIDE - Case discussions with structured threads and searchable archives - Voice and video calls β one-tap, with colleagues anywhere in India - Academic meetings β host journal clubs, CME, board meetings (recorded + transcribed) - Status updates β quick clinical posts visible for 24 hours - Document and DICOM sharing β radiology, lab reports, scans - Live location for emergency consults - End-to-end encrypted transit, encrypted at rest VERIFIED DOCTORS ONLY NephX is free, but access is gated by manual verification. Our admin team verifies medical credentials against Medical Council registries before activating each account. Patient confidentiality is a first-class design constraint, not an afterthought. NOT A MEDICAL DEVICE NephX is for peer academic discussion only. It is not a medical device, not a diagnostic tool, and not intended for direct patient care. BUILT BY THE NEPHX TEAM Developed by GeeApps for the Indian nephrology community. Free forever for verified members. Questions? Dr.VelArvind Subramaiam MD., DM., Email contact@nephx.app or call +91 96266 36000.
Screenshots
Verdict
The clearest difference is update cadence: NephX at every 8 days against Vidiyal's every 5 weeks. Vidiyal's advantage is iOS requirement (11.0 vs 17.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Vidiyal ships an update every 5 weeks, NephX every 8 days. The most recent releases landed on October 14, 2026 and October 12, 2026 respectively.
| Parameter | Vidiyal | NephX |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 5 weeks | Every 8 days β better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod | iPhone, iPad, Apple Watch |
| Requires iOS | 11.0 β better | 17.0 |
| Further details β not scored | ||
| Size | 46 MB | 123 MB |
| Age rating | 12+ | 17+ |
| Developer | TRANSPLANT AUTHORITY OF TAMIL NADU | Gobi Ganesan |
In-app purchases
Vidiyal
No in-app purchases
NephX
No in-app purchases







